Achieving diversity in clinical trials is critical to ensuring safe, effective therapies and equitable health outcomes, as well as fostering trust in healthcare research. Increasingly, planning for diversity is also a key component of regulatory compliance, as agencies such as the US Food and Drug Administration (FDA) issue guidance on ensuring that studies reflect the populations that will use the approved drugs and medical devices.
Strategic site selection is a key component of any plan to build diversity into a clinical trial. Partnering with sites that have proven diversity and implementing targeted interventions and communication strategies at the site level can help break down barriers to participation and create more inclusive trials
Download the guide by submitting the form below
Complete to download the guide
